NuVasive Inc (NASDAQ:NUVA)
| 22.33 Data as of May 24 |  +0.13 / +0.59%Today’s Change | 12.35 Today|||52-Week Range 25.99 | +44.44% Year-to-Date |
Latest NUVA News | Press Releases
No recent news for NuVasive Inc.
Today’s Trading
| Previous close | 22.20 |
| Today’s open | 22.13 |
| Day’s range | 21.82 - 22.43 |
| Volume | 709,159 |
| Average volume (3 months) | 412,164 |
| Market cap | $987.7M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/24/2013
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -2.28% |
| Earnings growth (next 5 years) | +11.63% |
| Revenue growth (last year) | +14.75% |
| P/E ratio | 319.0 |
| Price/Sales | 1.08 |
| Price/Book | 1.81 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABAXAbaxis Inc | +0.12 | +0.28% |
| IARTIntegra LifeSciences... | -0.11 | -0.30% |
| CPTSConceptus Inc | -0.01 | -0.03% |
| ARTCArthroCare Corp | +0.06 | +0.18% |
Data as of 4:00pm ET, 05/24/2013
Financials
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $0.24 |
| Annual revenue (last year) | $620.3M |
| Annual profit (last year) | $3.1M |
| Net profit margin | 0.51% |
Profile
Sector Health Technology |
Industry Medical Specialties |
Chairman & Chief Executive Officer Alexis V. Lukianov |
President & Chief Operating Officer Keith C. Valentine |
Corporate headquarters San Diego, California |
Forecasts
